Adalja AA, Toner E, Inglesby TV (2020) Priorities for the US Health Community responding to COVID-19. JAMA 323(14):1343–1344. https://doi.org/10.1001/jama.2020.3413
Article CAS PubMed Google Scholar
Ahmed S, Ansar Ahmed Z, Siddiqui I, Haroon Rashid N, Mansoor M, Jafri L (2021) Evaluation of serum ferritin for prediction of severity and mortality in COVID-19—a cross sectional study. Ann Med Surg (lond) 63:102163. https://doi.org/10.1016/j.amsu.2021.02.009
Alamer A, Alrashed AA, Alfaifi M et al (2021) Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. Curr Med Res Opin 37(7):1085–1097. https://doi.org/10.1080/03007995.2021.1920900
Article CAS PubMed Google Scholar
Alotaibi M, Ali A, Bakhshwin D, Alatawi Y, Alotaibi S, Alhifany A, Alharthi B, Alharthi N, Alyazidi A, Alharthi Y, Alrafiah A (2021) Effectiveness and safety of favipiravir compared to hydroxychloroquine for management of Covid-19: a retrospective study. Int J Gen Med 14:5597–5606. https://doi.org/10.2147/IJGM.S329881
Article PubMed PubMed Central Google Scholar
Alwafi H, Naser AY, Qanash S et al (2021) Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: a cross-sectional study. J Multidiscip Healthc 14:839–852. https://doi.org/10.2147/JMDH.S304788
Article PubMed PubMed Central Google Scholar
Bellan M, Patti G, Hayden E et al (2020) Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep 10(1):20731. https://doi.org/10.1038/s41598-020-77698-4
Article CAS PubMed PubMed Central Google Scholar
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O’Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y (2020) Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2020:ciaa478. https://doi.org/10.1093/cid/ciaa478
Birhanu A, Merga BT, Ayana GM, Alemu A, Negash B, Dessie Y (2022) Factors associated with prolonged length of hospital stay among COVID-19 cases admitted to the largest treatment center in Eastern Ethiopia. SAGE Open Med 10:20503121211070370. https://doi.org/10.1177/20503121211070366
Article PubMed PubMed Central Google Scholar
Birtay T, Bahadir S, Kabacaoglu E, Yetiz O, Demirci MF, Genctoy G (2021) Prognosis of patients hospitalized with a diagnosis of COVID-19 pneumonia in a tertiary hospital in Turkey. Ann Saudi Med 41(6):327–335. https://doi.org/10.5144/0256-4947.2021.327
Article PubMed PubMed Central Google Scholar
Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT (2021) Liver biochemistries in hospitalized patients with COVID-19. Hepatology 73(3):890–900. https://doi.org/10.1002/hep.31326
Article CAS PubMed Google Scholar
Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H (2020) Serum activity of liver enzymes is associated with higher mortality in COVID-19: a systematic review and meta-analysis. Front Med (lausanne) 7:431. https://doi.org/10.3389/fmed.2020.00431
Cai Q, Yang M, Liu D et al (2020) Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (beijing) 6(10):1192–1198. https://doi.org/10.1016/j.eng.2020.03.007
Article CAS PubMed Google Scholar
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R (2023). Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Chakraborty I, Maity P (2020) COVID-19 outbreak: migration, effects on society, global environment and prevention. Sci Total Environ 728:138882. https://doi.org/10.1016/j.scitotenv.2020.138882
Article ADS CAS PubMed PubMed Central Google Scholar
Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, Zhuang R, Hu B, Zhang Z (2020) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. Medrxiv. https://doi.org/10.1101/2020.03.22.20040758
Article PubMed PubMed Central Google Scholar
Cocchio S, Zabeo F, Facchin G, Piva N, Furlan P, Nicoletti M, Saia M, Tonon M, Mongillo M, Russo F, Baldo V (2022) The effectiveness of a diverse COVID-19 vaccine portfolio and its impact on the persistence of positivity and length of hospital stays: the Veneto region’s experience. Vaccines (basel) 10(1):107. https://doi.org/10.3390/vaccines10010107
Article CAS PubMed Google Scholar
Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA (2021) Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol 166(3):949–954
Article CAS PubMed Google Scholar
de Souza FSH, Hojo-Souza NS, Batista BDO, da Silva CM, Guidoni DL (2021) On the analysis of mortality risk factors for hospitalized COVID-19 patients: a data-driven study using the major Brazilian database. PLoS ONE 16(3):e0248580. https://doi.org/10.1371/journal.pone.0248580
Article CAS PubMed PubMed Central Google Scholar
Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W (2021) Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (engl Ed) 156(7):324–331. https://doi.org/10.1016/j.medcle.2020.11.015
Article CAS PubMed Google Scholar
Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21. https://doi.org/10.1016/S2213-2600(20)30116-8
Article CAS PubMed PubMed Central Google Scholar
Fortunato F, Martinelli D, Lo Caputo S, Santantonio T, Dattoli V, Lopalco PL, Prato R (2021) Sex and gender differences in COVID-19: an Italian local register-based study. BMJ Open 11(10):e051506. https://doi.org/10.1136/bmjopen-2021-051506
Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA (2021) Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 76(2):428–455. https://doi.org/10.1111/all.14657
Article CAS PubMed Google Scholar
Gedik TE, Unal D, Suzan V, Bag Soytas R, Arman P, Bektan Kanat B, Ulugerger Avci G, Suna Erdincler D, Doventas A, Yavuzer H (2023) The impact of COVID-19 pandemic on the geriatric inpatient unit. Curr Med Res Opin 39(2):259–265. https://doi.org/10.1080/03007995.2022.2148460
Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382(25):2411–2418. https://doi.org/10.1056/NEJMoa2012410
Article CAS PubMed Google Scholar
Guisado-Vasco P, Valderas-Ortega S, Carralón-González MM et al (2020) Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: a retrospective observational study (COQUIMA cohort). EclinicalMedicine 28:100591. https://doi.org/10.1016/j.eclinm.2020.100591
Article PubMed PubMed Central Google Scholar
Guo A, Lu J, Tan H, Kuang Z, Luo Y, Yang T, Xu J, Yu J, Wen C, Shen A (2021) Risk factors on admission associated with hospital length of stay in patients with COVID-19: a retrospective cohort study. Sci Rep 11(1):7310. https://doi.org/10.1038/s41598-021-86853-4
Article CAS PubMed PubMed Central Google Scholar
Havers FP, Pham H, Taylor CA et al (2022) COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US states, January 2021 to April 2022. JAMA Intern Med 182(10):1071–1081. https://doi.org/10.1001/jamainternmed.2022.4299
Article PubMed PubMed Central Google Scholar
Hernández-Galdamez DR, González-Block MÁ, Romo-Dueñas DK, Lima-Morales R, Hernández-Vicente IA, Lumbreras-Guzmán M, Méndez-Hernández P (2020) Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res 51(7):683–689. https://doi.org/10.1016/j.arcmed.2020.07.003
Article CAS PubMed PubMed Central Google Scholar
Ho TC, Wang YH, Chen YL, Tsai WC, Lee CH, Chuang KP, Chen YA, Yuan CH, Ho SY, Yang MH, Tyan YC (2021) Chloroquine and hydroxychloroquine: efficacy in the treatment of the COVID-19. Pathogens 10(2):217. https://doi.org/10.3390/pathogens10020217
Article CAS PubMed PubMed Central Google Scholar
Horwitz LI, Jones SA, Cerfolio RJ, Francois F, Greco J, Rudy B, Petrilli CM (2021) Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med 16(2):90–92. https://doi.org/10.12788/jhm.3552
Huang YZ, Kuan CC (2022) Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 26(5):1770–1776. https://doi.org/10.26355/eurrev_202203_28248
Huang M, Tang T, Pang P et al (2020) Treating COVID-19 with chloroquine. J Mol Cell Biol 12(4):322–325. https://doi.org/10.1093/jmcb/mjaa014
留言 (0)